Stefanos, who comes from Greece, 44 years old, is suffering from Polycystic Kidney Disease. Now, he is receiving Micro-Chinese Medicine Osmotherapy and Stem Cell Transplantation in Shijiazhuang kidney Disease Hospital, China.
Mike Dunkirk, describes on ABC News, how VesCell adult stem cell treatment has helped improve his life after suffering from heart disease
Read more from the original source:
Heart Disease Patient Describes His Stem Cell Treatment - Video
Dr. Sang-Mo Kang, UCSF transplant surgeon, discuses recent advancements in stem cell research that may lead to the regeneration of tissues and organs.
See the rest here:
What Organ Shortage? Just Make Your Own! Stem Cells and Organ Engineering - Video
Listen to testimony of a lady who had kidney failure recovered from her condition with stem cell nutrition.
Read more here:
Stem Cell Enhancer Treats Kidney Failure. More at http://www.stemcellfusion.com - Video
we search this hospital from the internet, and I feel that they are quite unique so i come to this hospital, after one month treatment, my kidney function gets improved dramatically, they use Micro-Chinese Medicine Osmotherapy and Stem Cell Transplant to make it!
See the rest here:
stem cells for renal failure.mpg - Video
http://www.jeteye.com Biologic Stem Cell Therapy is an amazing skin rejuvenation topical cream that reactivates the existing body processes that functioned to maintain skin health during youth. The beauty of Stem Cell Therapy cream is that it does not rely on foreign and invasive anti aging skin treatments but uses the natural elements already contained within the body.
Visit link:
Biologic Stem Cell Therapy Cream - Video
STEM CELL THERAPY FOR CHRONIC KIDNEY DISEASE - MUMBAI, AT SPECTRUM CELL CLINIC, Dr Sunil Waghmare, MD,DMRE,MACP,FACP,Fellow-ISVIR. Interventional Radiologist and Stem cell therapist.
Continued here:
STEM CELL FOR KIDNEY FAILURE - MUMBAI.wmv - Video
New Option Cells is a pioneering veterinary medical technology company offering personalised services to vets for the treatment of various types of pets.
Read the original here:
Veterinary Stem Cells Case Study Chrissy - Video
Actually I have lots of discomforts like edema , stoke and hypertention. You know they are caused by kidney problems.
See more here:
stem cells for PKD.mpg - Video
Medical School researchers John E. Wagner, MD, and Jakub Tolar, MD, Ph.D., have for the first time used stem cells from bone marrow to repair the skin of patients with a fatal skin disease called recessive dystrophic epidermolysis bullosa, or RDEB (EB). This is the first time researchers have shown that bone marrow stem cells can home to the skin and upper gastrointestinal tract and alter the natural course of the disease
View original post here:
Stem cells in bone marrow are being used to treat EB - Video
Brought to you by the Howard Hughes Medical Institute, this lecture by Dr. Douglas A.
Go here to read the rest:
Regenocyte Therapeutic is the first clinically treating stem cell center based in the United States. Its international team of Board Certified physicians and scientists use adult stem cells taken directly from the patients own blood or bone marrow to treat serious health conditions like congestive heart failure, cardiomyopathy, severe pulmonary diseases, kidney dysfunction, circulation/vascular diseases, dementia, and macular degeneration.
Link:
Learn more at ?ProGenaCell.com Kidney function improves after alternative treatment of stem cells are administered to a young boy.
Go here to see the original:
Alternative Treatments for Chronic Kidney Disease MPGN - Video
General information about stem cell treatments of stem cell therapies obtained from Bone Marrow at Progencell for degenerative diseases.
Originally posted here:
Cellonis Diabetes Stem Cell Therapy: A Chance for Insulin Independence and the Reversal of Complications
BEIJING, June 24 /PRNewswire-Asia/ -- Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients' conditions. The ongoing clinical study shows the treatment's best case could reconstruct a patient's natural insulin production and even reverse later complications like kidney failure. Treated patients may have the chance to return to the normal activities non-diabetes sufferers take for granted.
The clinical study, jointly conducted by scientists and doctors of the Cellonis clinical research team, aims to help patients be free from insulin and oral drugs, by reconstructing their natural insulin production damaged by either autoimmune disorder (T1DM) or hyperglycemia and also improve insulin sensitivity (T2DM). Using injections of autologous stem cells from the patient's bone marrow, the research team believes that this therapy could help patients return to a life without annoying everyday injections and drugs.
"Most of the patients in our clinical study are now taking less synthetic insulin or oral drugs for BG control," says Dr. Chase Dai, Chief Medical Officer at Cellonis. "We appear to have restored the biological insulin producing function of the body. We are excited to see that some patients have been treatment-free for five months now, and we believe the effect of the stem cell therapy can last much longer. We were also encouraged by some other happy surprises during the clinical study.
"For example, this therapy appears to reverse chronic kidney failure. It was a surprise for all of my team to observe that the kidney function of a 75- year-old patient improved remarkably."
This patient had suffered from diabetes for years, gradually developing diabetic foot and nephropathy. He can now walk freely after having been confined to bed or a wheelchair for six months, and his quality of life has improved significantly. Moreover, he only needs kidney dialysis one time a week instead of three times. In a follow-up visit he excitedly told us that he was hopeful that in the near future he could be completely rid of diabetes.
Diabetes, an increasingly spreading disease, can lead to life-threatening diseases such as blindness, amputation, strokes, or kidney failure in its natural course. Current treatments, including insulin, cannot change this situation.
"We believe that our stem cell therapy will bring promising hope for patients suffering from diabetes and its complications," comments Cindy Hao, CEO of Cellonis. "Personalized diabetes therapies for patients of various conditions will be developed by Cellonis in the near future. We believe what we have restored for patients will not only be their natural insulin production, but also a normal life filled with the activities non-diabetes sufferers can enjoy daily."
Cellonis Biotechnologies focuses on R&D and the clinical application of novel personalized stem cell therapies and immunotherapies for patients with diseases including cancer, diabetes and central nervous system disorders.
Unproven treatment results in mysterious masses.
David Cyranoski
In a stark reminder that stem-cell therapy is uncharted territory, a stem-cell transplant given to a patient in Thailand who had kidney disease resulted in the development of cellular masses not previously reported. The lesions, described in a paper published online on 17 June in the Journal of the American Society of Nephrology, were not directly linked to the patient's subsequent death (D. Thirabanjasak et al. J. Am. Soc. Nephrol. doi:10.1681/ASN.2009111156; 2010).
With hundreds of poorly regulated clinics that offer unproven stem-cell therapies now running, notably in China and Thailand, the episode is a warning to patients who may be considering such treatment.
The patient had lupus nephritis, in which the immune system attacks the kidneys. In 2006, she underwent a procedure at a private clinic in which her own haematopoietic stem cells — which can develop into any type of blood cell — were injected into her kidneys. Details of the clinic and the rationale behind the treatment have not been released.
“She didn’t get any better from stem cells, we can say that.”
Haematopoietic stem cells have been used to treat lupus nephritis with some reports of success. But they are usually injected into the bloodstream, not the kidney, in an attempt to 'reset' the immune system.
Six months later, the patient complained of pain and blood in the urine. Imaging studies revealed a four-centimetre mass on her left kidney and smaller masses in the kidney, liver and adrenal gland. Doctors at Chulalongkorn University in Bangkok removed the kidney, believing a malignant tumour to be present. But further analysis showed that it was something else.
"I had never seen anything like it," says Paul Thorner, a pathologist at the Hospital for Sick Children in Toronto, Canada, who has a joint position at Chulalongkorn University (thailand) and was a co-author on the paper. Thorner coined a term — angiomyeloproliferative — to describe the proliferation of blood-vessel and bone-marrow cells the team found.
Patients are undergoing other experimental stem-cell therapies, but there is usually little follow-up to establish safety or efficacy. In one case reported last year, a boy treated with fetal stem cells at a Russian clinic developed tumours in his brain and spinal cord. In the Thai case, no post-mortem was carried out, as far as Thorner is aware, so his team could work only on the removed kidney. It is not known whether the smaller masses were linked to the main mass, or what would have happened had the patient not died from other complications. "She didn't get any better from stem cells, we can say that," says Thorner, who may try to reproduce the masses in animal experiments.
source: naturenews